Phospholipids inhibit lipopolysaccharide (LPS)-induced cell activation: A role for LPS-binding protein

Journal of Immunology

Volumn 174, Issue 2, 2005, Pages 1091-1096

  Mueller, Mareile ^a   Brandenburg, Klaus ^a   Dedrick, Russ ^b   Schromm, Andra B ^a   Seydel, Ulrich ^a  

^a RESEARCH CENTER BORSTEL   (Germany)

^b XOMA Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOLYTE; CARDIOLIPIN; CD14 ANTIGEN; LIPID A; LIPOPOLYSACCHARIDE; LIPOPOLYSACCHARIDE BINDING PROTEIN; LIPOSOME; MEMBRANE RECEPTOR; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLGLYCEROL; PHOSPHATIDYLSERINE; PHOSPHOLIPID; SPHINGOMYELIN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL ACTIVATION; CELL MEMBRANE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; INTERCALATION COMPLEX; MACROPHAGE; MONONUCLEAR CELL; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 11844301359     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.2.1091     Document Type: Article

References (38)

1. Hardaway, R. M. 2000. A review of septic shock. Am. Surg. 66:22.
2. Cohen, J. 2002. The immunopathogenesis of sepsis. Nature 420:885.
3. Luderitz, O., C. Galanos, V. Lehmann, H. Mayer, E. T. Rietschel, and J. Weckesser. 1978. Chemical structure and biological activities of lipid A's from various bacterial families. Naturwissenschaften 65:578.
4. Schromm, A. B., K. Brandenburg, H. Loppnow, A. P. Moran, M. H. Koch, E. T. Rietschel, and U. Seydel. 2000. Biological activities of lipopolysaccharides are determined by the shape of their lipid A portion. Eur. J. Biochem. 267:2008.
5. Rietschel, E. T., H. Brade, L. Brade, K. Brandenburg, U. Schade, U. Seydel, U. Zahringer, C. Galanos, O. Luderitz, and O. Westphal. 1987. Lipid A, the endotoxic center of bacterial lipopolysaccharides: relation of chemical structure to biological activity. Prog. Clin. Biol. Res. 231:25.
6. Loppnow, H., H. Brade, I. Dürrbaum, C. A. Dinarello, S. Kusumoto, E. T. Rietschel, and H.-D. Flad. 1989. IL-1 induction-capacity of defined lipopolysaccharide partial structures. J. Immunol. 142:3229.
7. Kovach, N. L., E. Yee, R. S. Munford, C. R. H. Raetz, and J. M. Harlan. 1990. Lipid IVa inhibits synthesis and release of tumor necrosis factor induced by lipopolysaccharide in human whole blood ex vivo. J. Exp. Med. 172:77.
8. Brandenburg, K., L. Hawkins, P. Garidel, J. Andra, M. Muller, H. Heine, M. H. Koch, and U. Seydel. 2004. Structural polymorphism and endotoxic activity of synthetic phospholipid-like amphiphiles. Biochemistry 43:4039.
9. Seydel, U., L. Hawkins, A. B. Schromm, H. Heine, O. Scheel, M. H. Koch, and K. Brandenburg. 2003. The generalized endotoxic principle. Eur. J. Immunol. 33:1586.
10. Sugawara, E., and H. Nikaido. 1992. Pore-forming activity of OmpA protein of Escherichia coli. J. Biol. Chem. 267:2507.
11. Kutuzova, G. D., R. M. Albrecht, C. M. Erickson, and N. Qureshi. 2001. Diphosphoryl lipid A from Rhodobacter sphaeroides blocks the binding and internalization of lipopolysaccharide in RAW 264.7 cells. J. Immunol. 167:482.
12. Ramadori, G., z. B. K. Meyer, P. S. Tobias, J. C. Mathison, and R. J. Ulevitch. 1990. Biosynthesis of lipopolysaccharide-binding protein in rabbit hepatocytes. Pathabiology 58:89.
13. Yu, B., E. Hailman, and S. D. Wright. 1997. Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids. J. Clin. Invest. 99:315.
14. Schumann, R. R., S. R. Leong, G. W. Flaggs, P. W. Gray, S. D. Wright, J. C. Mathison, P. S. Tobias, and R. J. Ulevitch. 1990. Structure and function of lipopolysaccharide binding protein. Science 249:1429.
15. Wurfel, M. M., B. G. Monks, R. R. Ingalls, R. L. Dedrick, R. Delude, D. Zhou, N. Lamping, R. R. Schumann, R. Thieringer, M. J. Fenton, et al. 1997. Targeted deletion of the lipopolysaccharide (LPS)-binding protein gene leads to profound suppression of LPS responses ex vivo, whereas in vivo responses remain intact. J. Exp. Med. 186:2051.
16. Jack, R. S., X. Fan, M. Bernheiden, G. Rune, M. Ehlers, A. Weber, G. Kirsch, R. Mentel, B. Fürli, M. Freudenberg, et al. 1997. Lipopolysaccharide-binding protein is required to combat a murine Gram-negative bacterial infection. Nature 389:742.
17. Gutsmann, T., N. Haberer, U. Seydel, and A. Wiese. 2001. Interaction between lipopolysaccharide (LPS), LPS-binding protein (LBP), and planar membranes. Biol. Chem. 382:425.
18. Gutsmann, T., M. Muller, S. F. Carroll, R. C. MacKenzie, A. Wiese, and U. Seydel. 2001. Dual role of lipopolysaccharide (LPS)-binding protein in neutralization of LPS and enhancement of LPS-induced activation of mononuclear cells. Infect. Immun. 69:6942.
19. Poltorak, A., X. He, I. Smirnova, M. Y. Liu, C. V. Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, et al. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:2085.
20. Hoshino, K., O. Takeuchi, T. Kawai, H. Sanjo, T. Ogawa, Y. Takeda, K. Takeda, and S. Akira. 1999. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162:3749.
21. Shimazu, R., S. Akashi, H. Ogata, Y. Nagai, K. Fukudome, K. Miyake, and M. Kimoto. 1999. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 189:1777.
22. Schromm, A. B., E. Lien, P. Henneke, J. C. Chow, A. Yoshimura, H. Heine, E. Latz, B. G. Monks, D. A. Schwartz, K. Miyake, and D. T. Golenbock. 2001. Molecular genetic analysis of an endotoxin nonresponder mutant cell line: a point mutation in a conserved region of MD-2 abolishes endotoxin-induced signaling. J. Exp. Med. 194:79.
23. + channel in transmembrane signaling. J. Immunol. 166:1009.
24. Triantafilou M, Miyake K, D. T. Golenbock, and Triantafilou K. 2002. Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation. J Cell Sci. 115:2603.
25. Galanos, C., O. Lüderitz, and O. Westphal. 1969. A new method for the extraction of R lipopolysaccharides. Eur. J. Biochem. 9:245.
26. Theofan, G., A. H. Horwitz, R. E. Williams, P.-S. Liu, I. Chan, C. Birr, S. F. Carroll, K. Mészáros, J. B. Parent, H. Kasler, et al. 1994. An amino-terminal fragment of human lipopolysaccharide-binding protein retains lipid A binding but not CD14-stiraulatory activity. J. Immunol. 152:3623.
27. Grage-Griebenow, E., D. Lorenzen, R. Fetting, H. D. Flad, and M. Ernst. 1993. Phenotypical and functional characterization of Fcγ receptor I (CD64)-negative monocytes, a minor human monocyte subpopulation with high accessory and antiviral activity. Eur. J. Immunol. 23:3126.
28. Gallati, H. 1982. Interferon: a greatly simplified immunoenzyme determination with two monoclonal antibodies. J. Clin. Chem. Clin. Biochem. 20:907.
29. Struck, D. K., D. Hoekstra, and R. E. Pagano. 1981. Use of resonance energy transfer to monitor membrane fusion. Biochemistry 20:4093.
30. Schromm, A. B., K. Brandenburg, E. Th. Rietschel, H.-D. Flad, S. F. Carroll, and U. Seydel. 1996. Lipopolysaccharide binding protein (LBP) mediates CD14-independent intercalation of lipopolysaccharide into phospholipid membranes. FEBS Lett. 399:267.
31. Kröner, E. E., B. A. Peskar, H. Fischer, and E. Ferber. 1981. Control of arachidonic acid accumulation in bone marrow-derived macrophages by acyltransferases. J. Biol. Chem. 256:3690.
32. Wright, S. D., R. A. Ramos, P. S. Tobias, R. J. Ulevitch, and J. C. Mathison. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431.
33. Muller, M., O. Scheel, B. Lindner, T. Gutsmann, and U. Seydel. 2003. The role of membrane-bound LBP, endotoxin aggregates, and the MaxiK channel in LPS-induced cell activation. J. Endotoxin Res. 9:181.
34. 99) of lipopolysaccharide (LPS)-binding protein on binding and transfer of LPS and subsequent immune cell activation. J. Immunol. 157:4648.
35. Wang, P. Y., R. L. Kitchens, and R. S. Munford. 1998. Phosphatidylinositides bind to plasma membrane CD14 and can prevent monocyte activation by bacterial lipopolysaccharide. J. Biol. Chem. 273:24309.
36. Bochkov, V. N., A. Kadl, J. Huber, F. Gruber, B. R. Binder, and N. Leitinger. 2002. Protective role of phospholipid oxidation products in endotoxin-induced tissue damage. Nature 419:77.
37. Hashimoto, M., Y. Asai, and T. Ogawa. 2003. Treponemal phospholipids inhibit innate immune responses induced by pathogen-associated molecular patterns. J. Biol. Chem. 278:44205.
38. Dijkstra, J., J. W. Mellors, J. L. Ryan, and F. C. Szoka. 1987. Modulation of the biological activity of bacterial endotoxin by incorporation into liposomes. J. Immunol. 138:2663.